Molecular Diagnosis & Therapy
Molecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use in precision medicine.
Via a program of reviews and original research articles, the journal is focused on linking diagnostic and prognostic biomarkers to appropriate therapy, with an emphasis on the development of companion diagnostic/therapeutic products, along with the analysis of pharmacogenomic data for drug developmentand therapeutic decision making.
Molecular Drugs & Therapy offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself.
Letter to the Editor
Comment on “Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients”
Go J. Yoshida (August 2018)
Original Research Article
The Presence of HLA-A Bw4-80I KIR Ligands Could Predict “Difficult-to-Treat” Psoriasis and Poor Response to Etanercept
- Journal Title
- Molecular Diagnosis & Therapy
- Volume 5 / 2000 - Volume 22 / 2018
- Print ISSN
- Online ISSN
- Springer International Publishing
- Additional Links
- Industry Sectors
|Previous Title||Print ISSN||Online ISSN|
To view the rest of this content please follow the download PDF link above.